Laidlaw reissued their hold rating on shares of Evofem Biosciences (NASDAQ:EVFM – Free Report) in a report published on Wednesday, Benzinga reports. Evofem Biosciences Trading Down 23.5 % Shares of EVFM stock opened at $0.07 on Wednesday. The stock has a 50 day moving average of $0.08 and a 200 day moving average of $0.35. […]
Evofem Biosciences (NASDAQ:EVFM – Get Free Report) posted its quarterly earnings data on Tuesday. The biotechnology company reported $0.10 EPS for the quarter, reports. Evofem Biosciences had a net margin of 344.82% and a negative return on equity of 77.85%. The firm had revenue of $5.11 million for the quarter. Evofem Biosciences Trading Down 10.6 […]
Equities analysts predict that Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Rating) will report sales of $6.65 million for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Evofem Biosciences’ earnings. The lowest sales estimate is $5.50 million and the highest is $8.56 million. Evofem Biosciences reported sales of $1.86 million in the […]
Investment analysts at Laidlaw assumed coverage on shares of Evofem Biosciences (NASDAQ:EVFM – Get Rating) in a research note issued on Thursday, The Fly reports. The brokerage set a “buy” rating on the biotechnology company’s stock. Separately, Morgan Stanley boosted their price target on Evofem Biosciences from $7.95 to $8.55 and gave the company an […]
Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Rating) CEO Saundra L. Pelletier purchased 141,000 shares of the firm’s stock in a transaction that occurred on Friday, May 27th. The stock was bought at an average cost of $0.35 per share, for a total transaction of $49,350.00. Following the purchase, the chief executive officer now owns 236,722 […]